The IBD SmartSelect Composite Rating for Xometry rose from 94 to 96 Tuesday.
The upgrade means the stock is now outperforming 96% of all other stocks in terms of key performance metrics and technical strength. History shows the top market performers tend to have a 95 or higher score as they launch their major moves.
Xometry is now out of buy range after breaking out from a 20.91 entry in a consolidation.
Looking For The Best Stocks To Buy And Watch? Start Here
One weak spot is the company's 75 EPS Rating, which tracks quarterly and annual earnings-per-share growth. Look for that to improve to 80 or better to show it's in the top 20% of all stocks.
Its Accumulation/Distribution Rating of A shows heavy buying by institutional investors, such as mutual funds and pension funds, over the last 13 weeks.
In Q3, the company posted 0% earnings growth. Top line growth was flat, matching the prior report's 19%.
Xometry earns the No. 1 rank among its peers in the Machinery-Materials Handling industry group. Proto Labs and Columbus McKinnon are also among the group's highest-rated stocks.
